Dr. Leider most recently served as chief medical officer of Gelesis, a biotechnology company that developed a medical device to treat obesity. He also was the chief medical officer of Walgreens, where he focused on clinical program development and global executive leadership.
In his role at AposHealth, Dr. Leider will oversee the company’s payer and engagement services. He will also serve on the company’s senior leadership team and focus on provider network development and medical affairs functions, according to a Jan. 17 release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
